Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03533751

Public ClinicalTrials.gov record NCT03533751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects With Moderate-to-Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to evaluate the efficacy, safety, and pharmacokinetic (PK) profiles of multiple doses of etokimab in adult participants with atopic dermatitis (AD).

Study identification

NCT ID
NCT03533751
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AnaptysBio, Inc.
Industry
Enrollment
302 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2018 (Actual)
Primary completion
Dec 3, 2019 (Actual)
Completion
Dec 3, 2019 (Actual)
Last update posted
May 24, 2023

2018 – 2019

United States locations

U.S. sites
37
U.S. states
23
U.S. cities
37
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Applied Research Center of Arkansas Little Rock Arkansas 72212 —
Encino Research Group Encino California 91436 —
Irvine Center for Clinical Research, Inc. Irvine California 92614 —
Clinical Science Institute Santa Monica California 90404 —
Medical Research Center of Miami Miami Florida 33134 —
Compass Research Main Orlando Florida 32806 —
Moore Clinical Research Inc. - Brandon Tampa Florida 33609 —
Georgia Pollens Clinical Research Centers, Inc. Albany Georgia 31707 —
Dermatologic Surgery Specialists Macon Georgia 31217 —
Marietta Dermatology & The Skin Cancer Center - Marietta Marietta Georgia 30060-1047 —
Advanced Medical Research, PC Sandy Springs Georgia 30328 —
Midwest Allergy, Sinus and Asthma, SC Normal Illinois 61761 —
Kansas City Dermatology, PA Overland Park Kansas 66215-2314 —
DermResearch, PLLC Louisville Kentucky 40217 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215-5400 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
Grekin Skin Institute - Warren Warren Michigan 48088 —
Washington University School of Medicine St Louis Missouri 63141 —
Skin Specialists, PC Omaha Nebraska 68144 —
JDR Dermatology Research Las Vegas Nevada 89148 —
The Dermatology Group Verona New Jersey 07044-2946 —
Albuquerque Clinical Trials, Inc. Albuquerque New Mexico 87102 —
Forest Hills Dermatology Group Forest Hills New York 11375 —
SRG New York New York 10021 —
DermResearch Center of New York Stony Brook New York 11790 —
Wilmington Dermatology Center Wilmington North Carolina 28403 —
Ohio State University Clinical Trials Management Office Columbus Ohio 43210 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Vital Prospects Clinical Research Institute, P.C. Tulsa Oklahoma 74136 —
Clinical Research Institute of Southern Oregon, PC Medford Oregon 97504 —
Clinical Partners, LLC Johnston Rhode Island 02919 —
Coppell Allergy and Asthma PA Coppell Texas 75019 —
Dermatology Treatment and Research Center Dallas Texas 75230 —
Center for Medical Research Houston Texas 77056 —
Progressive Clinical Research, PA San Antonio Texas 78213 —
Clinical Research Partners, LLC Richmond Virginia 23220 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03533751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 24, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03533751 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →